De Schepper P J, Van Hecken A, Daenens P, Van Rossum J M
Eur J Clin Pharmacol. 1987;31(5):583-8. doi: 10.1007/BF00606635.
Cotinine, the main metabolite of nicotine, was administered intravenously to healthy male non-smoking volunteers in doses of 5, 10 and 20 mg, and orally in doses of 10 and 20 mg. Intravenous administration was characterized by a dose-independent half-life of 12.2 h, mean residence time of 15.9 h, total clearance of 3.64 l h-1 and a volume of distribution of 56.5 l. Renal clearance was 0.46 l h-1 and approximately 12.0% of the dose was excreted unchanged in the urine. The mean absorption time after oral dosing ranged between 1 and 3 h, the peak concentration was reached within 45 min and the mean elimination half-lives were 12.9 and 11.7 h, respectively, after the 10 and 20 mg doses. Systemic bioavailability ranged between 0.84 and 1.11 following 10 mg and between 0.97 and 1.03 following the 20 mg dose. Mean urinary recovery and renal clearance were almost identical with the values after iv administration.
可替宁是尼古丁的主要代谢产物,以5毫克、10毫克和20毫克的剂量静脉注射给健康的非吸烟男性志愿者,并以10毫克和20毫克的剂量口服。静脉注射的特点是剂量依赖性半衰期为12.2小时,平均驻留时间为15.9小时,总清除率为3.64升/小时,分布容积为56.5升。肾清除率为0.46升/小时,约12.0%的剂量以原形从尿液中排出。口服给药后的平均吸收时间为1至3小时,45分钟内达到峰值浓度,10毫克和20毫克剂量后的平均消除半衰期分别为12.9小时和11.7小时。10毫克剂量后的全身生物利用度在0.84至1.11之间,20毫克剂量后的全身生物利用度在0.97至1.03之间。平均尿回收率和肾清除率与静脉注射后的数值几乎相同。